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Obiectives. The decision to provide mechanical ventilation 
(intermittent positive pressure ventilation (IPPV)) to HIV-
exposed infants in resource-poor settings has remained 
difficult owing to problems in confirming HIV infection and 
the lack of data on outcome. We evaluated the predictive 
value of the HIV antibody test in confirming infection in 
infants requiring mechanical ventilation for acute lower 
respiratory infections (ALRis), and compared the outcome for 
children denied access with the outcome for similar subjects 
who were ventilated. 
Setting and design. This investigative study was conducted 
over a 12-month period at the paediatric intensive care unit 
(PICU) at King Edward VIII Hospital (KEH) in Durban, and 
at Ngwelezana Hospital in northern KwaZulu-Natal. 
Subjects. HIV-exposed patients with acute respiratory failure 
(ARF) secondary to ALRI entering the PICU at KEH were 
enrolled into the IPPV arm, while similar children who were 
refused such care at Ngwelezana Hospital were admitted into 
the non-IPPV arm. Standardised protocols for entry and 
management of enrolled subjects were utilised. 
Outcome measures. HIV DNA polymerase chain reaction (PCR) 
testing was performed to establish HIV status. Clinical and 
laboratory parameters were correlated with HIV status to 
determine predictors of infection and outcome (survival to 
In developing countries HIV infection in infancy is a major 
problem because of the uncertainties of diagnosis and the 
paucity of evidence on outcome following mechanical 
ventilation. Acute lower respiratory infection (ALRI) is a 
common complication among HIV-infected children, 
accounting for 30 - 40% of inpatient admissions and a case 
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discharge). 
Results. One hundred and sixteen HIV-exposed infants were 
enrolled, 49 into the IPPV arm and 67 into the non-JPPV arm. 
The median age of both groups was 3.0 months (0.5 - 11 
months), and the male/female ratio and proportion of infants 
under 3 months of age were similar in both groups. 
The predictive values of the HIV antibody test in 
determining HIV infection in the IPPV and nonciPPV arms 
were 87.8% and 85.0 % respectively. Splenomegaly and a 
serum globulin of >35 g/l increased the likelihood of being 
HIV PCR- positive (p = 0.006 and p = 0.04 respectively). 
Survival to discharge rates for HIV-infected children in the 
IPPV and non-IPPV arms were 41.9% and 24.6% respectively 
(p = 0.08). Age less than 3 months (p = 0.04) and very severe 
pneumonia (p = 0.007) were the only indicators of poor 
outcome. 
Conclusion. Mechanical ventilation provided little benefit in 
HIV-infected children with ARF from ALRI. An HIV 
antibody test in infants with ALRI and ARF is highly 
suggestive of HIV infection. Splenomegaly and a serum 
globulin of greater than 35 g/l were the only useful markers 
in identifying HIV infection. 
5 Afr Med J 2003; 93:617-620. 
. 
fatality rate of 15- 28% in southern AfricaY The diagnosis of 
HIV infection in infants is problematic due to transplacental 
transmission of maternal HIV-1 antibodies, and the 
unavailability of confirmatory HIV DNA polymerase chain 
reaction (PCR) tests because of cost constraints. The World 
Health Organisation (WHO) proposed a clinical case definition 
for paediatric AIDS that is neither sensitive nor specific in 
confirming infection.' The decision to provide mechanical 
ventilation for HIV-exposed infants with severe HIV-related 
pneumonia is influenced by considerations of ethics, costs and 
likely benefits. There is no uniform opinion to assist clinicians 
in making such decisions. 
At Ngwelezana and King Edward VIII hospitals in 
KwaZulu-Natal, where the public sector antenatal HIV 
prevalence rate is 36%, this dilemma is faced weekly.' We 
studied HIV-exposed children (less than 15 months of age) 
with severe or very severe pneumonia requiring mechanical 
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ventilation to evaluate the usefulness of HIV antibody tests in 
predicting infection. We also compared the outcome of children 
receiving intermittent positive-pressure ventilation (IPPV) with 
that of similar children who were denied such care. 
Patients and methods 
An investigative study (June 1999- May 2000) was conducted 
at the paediatric intensive care unit (PICU) at King Edward 
VIII Hospital (KEH) and the paediatric wards at Ngwelezana 
Hospital in KwaZulu-Natal, South Africa. The PICU at KEH is 
the only public sector intensive care service available to a 
paediatric population of 3 - 4 million. Approximately 400 
children are admitted annually, with an overall mortality rate 
of 25%.5 The unit has a bed capacity of 10 and an occupancy 
rate of over 90%. The unit is staffed by 2 consultants and 4 
registrars/medical officers. The nurse-to-patient ratio is 1:3. 
Criteria for entry into the unit included the need for airway 
support, and invasive and non-invasive monitoring. 
Ngwelezana Hospital is a subregional facility serving a rural 
and peri-urban population of 2 million. There are 140 
paediatric beds, including 9 for high care. Forty-five per cent of 
the 13 daily paediatric admissions are for ALRI, while 75% of 
those tested for HIV are positive. A consultant and 7 medical 
officers make up the staff complement. The nurse-to-patient 
ratio in the paediatric high care unit is 1:5. HIV antibody tests 
(enzyme-linked immunosorbent assay (ELISA) or the Rapid 
Stat test) are usually available but results for HIV DNA PCR 
confirmatory tests take 2 weeks. Transportation of babies to the 
PICU at KEH takes on average 6- 12 hours after acceptance. 
HIV-exposed children less than 15 months of age with ALRI 
were recruited if they fulfilled one or more of the following 
criteria: oxygen saturation < 89% on 2 1 of nasopharyngeal 
oxygen or 8 I of head box oxygen, type 1 or type 2 respiratory 
failure on 2 1 of nasopharyngeal oxygen; prolonged apnoea, 
and persistent metabolic acidosis (pH < 7.25) after 8 hours of 
fluid resuscitation. Children who received sustained IPPV were 
included in the ventilated arm while those denied ventilation 
due to lack of facilities were included in the non- ventilated 
arm. Babies who failed to thrive, those with WHO- defined 
paediatric AIDS, and previous HIV-related PICU admissions 
were not admitted to the PICU. At Ngwelezana, patients were 
cared for in high care ,or in a general ward. 
Identical admission laboratory tests, viz. a full blood count, 
electrolytes, liver function tests, HIV ELISA or Rapid Stat test, 
HIV DNA PCR, blood gases and radiology, were performed in 
both groups. HIV antibody-positive children were regarded as 
HIV-exposed, while HIV DNA PCR-positive children were 
regarded as HIV-infected. Antimicrobial therapy was 
prescribed according to WHO guidelines for severe and very 
severe pneumonia. High-dose intravenous cotrimoxazole and 
corticosteroids were used for cases of Pneumocystis carinii. 
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Failure to respond to these medications within 72 hours 
resulted in an empirical change to cefotaxime and amikacin at 
both institutions unless microbiological culture results 
indicated otherwise. The need for oxygen therapy, 
physiotherapy, blood transfusions and fluid and feeding 
practices were standardised for both sites before 
commencement of the study. An in-house nested HIV DNA 
PCR that targets a conserved region of the HIV gag gene was 
used to detect the presence of HIV proviral DNA. The 
amplification of a visible 160 base pair product in ethidium 
bromide-stained agarose gels was regarded as positive for HIV 
infection. 
A leaflet in the native language of participants explaining the 
need for the HIV test was given to all possible subjects before 
enrolment. Informed consent for HIV testing was granted in all 
cases. HIV testing was performed with pre- and post-test 
counselling and parents were offered the option of being 
blinded to these results. Where facilities for intensive care were 
not available, parents I guardians were informed accordingly. 
The study protocol received ethical approval from the 
University of Natal and the Medical Superintendent of 
Ngwelezana Hospital. 
The principal dependent variable for analysis was outcome 
defined as 'survival to discharge'. Capture and analysis of data 
were carried out using EPHnfo version 6.04 (Centers for 
Disease Control, Atlanta). Analysis of anthropometric data, 
lymphocyte count and serum protein gap required 
stratification of the sample. The median value was used as the 
cut-off point. p-values are reported. 
Results 
One hundred and sixteen children were enrolled during the 
study period, 67 in the non-ventilated arm at Ngwelezana and 
49 in the ventilated arm at KEH. Ten patients at Ngwelezana 
Hospital who presented in extremis and who were supported 
suboptimally on a transport ventilator were included into the 
non-ventilated arm for the analysis of outcome. The median 
age of both groups was 3.0 months (range 0.5 - 11 months). The 
male/female ratio was 1:1.63 and 1:1.04 for Ngwelezana and 
KEH respectively. The differences in the clinical characteristics 
between the two groups are shown in Table I. 
Of the 116 children recruited, 100 (86.2%) were PCR-positive, 
being similarly represented in the Ngwelezana and KEH 
cohorts (85.0% and 87.8% respectively) (Table II). The presence 
of splenomegaly (p == 0.006) and a serum globulin level of 
> 35 g/1 (p = 0.04) were associated with an increased likelihood 
of being HIV DNA PCR-positive. No association could be 
found between the HIV-exposed and infected children for age 
less than or greater than 3 months (p = 0.75), sex (p = 0.34), 
nutritional status (mean z-score less than or greater than 3, 
p = 0.21), hepatomegaly (p == 0.24), lymphadenopathy (p == 0.2), 
Table I. Differences in the clinical characteristics of cases receiving and not receiving mechanical ventilation 
HIV-exposed, 
Variables no IPPV (N = 67) 
Z-score (3 SD) -1.86 (1.23) 
Lymphadenopathy (N (%)) 
Yes 17 (25.4) 
No 50 (74.6) 
Paediatric AIDS (WHO) (N (%)) 
Yes 27 (40.3) 
No 40 (59.7) 
Severity of pneumonia (N (%)) 
Severe 43 (64.2) 
Very severe 24 (35.8) 
IPPV ::;:: intermittent positive pressure ventilation; SD = standard deviations, 
Table II. HIV infectivity and survival among HIV antibody-
positive children receiving and not receiving mechanical 
ventilation (N (%)) 
Variables 
HIV DNA PCR-positive 
HIV DNA PCR-negative 
Survival 
HIV DNA PCR-positive 
HIV DNA PCR-negative 
HIV antibody-
positive, no IPPV 









18 I 43 (41.9) 
416 (66.7) 
previous hospitalisations (p = 0.28), lymphocyte counts 
(p = 0.93) or WHO-defined paediatric AIDS (p = 0.27). 
There was no statistically significant difference between the 
survival to discharge of HIV DNA PCR-positive children who 
received IPPV and that of children who did not receive IPPV 
(41.9% v. 24.6%, p = 0.08) (Table II). The survival to discharge 
for cases with negative HIV DNA PCR results were similar for 
those receiving IPPV and those not ventilated (66.7% v. 60%, 
p = 0.20). Overall, the survival to discharge of HIV DNA PeR-
negative children was higher than that for HIV DNA PeR-
positive children (63% v. 32%, p = 0.02). 
At both sites, age less than 3 months compared with age 
above 3 months (OR 2.3, p = 0.04) and WHO-defined very 
severe pneumonia (OR 3.37, p = 0.007) were predictive of poor 
outcome. Failure to thrive (p = 1.00), previous hospital 
admissions (p = 0.84), hepatomegaly (p = 0.86), splenomegaly 
(p = 0.74), lymphadenopathy (p = 0.04), WHO-defined clinical 
AIDS (p =' 0.86), a high serum globulin level (p = 0.23) and a 
low total lymphocyte count (p = 0.2) were of no prognostic 
value in determining outcome. 
The median lengths of stay for all patients and survivors at 
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HIV-exposed, 
IPPV (N= 49) p-value 
-0.78 (1.41) 0.003 
23 (46.9) 0.05 
26 (53.1) NS 
3 (6.1) <0.01 
46 (93.9) < 0.001 
17 (34.7) 0.001 
32 (65.3) 0.001 
KEH were 10 (range 1 - 50) and 9 (range 1 - 50) days 
respectively. At Ngwelezana the median lengths of stay for all 
patients and survivors were 4 (range 0- 34) and 9 (range 3 - 20) 
days respectively. The median duration of IPPV and ICU stays 
were 9 and 16 days respectively. 
P. carinii pneumonia (PCP) (N = 16), mixed infections (PCP, 
Candida, cytomegalovirus and bacteria N = 9), nosocomial 
Gram-negative bacteria (Acinetobacter anitratus and Klebsiella 
pneumoniae N = 8), and community-acquired bacterial 
pneumonia (Staphylococcus aureus and Streptococcus pneumoniae 
N = 7) were the common pathogens identified in the HIV DNA 
PCR-positive cohort receiving intensive care. Bordete/la pertussis 
(N = 2), S. aureus (N = 2), Moraxella catarrhalis (N = 1) and 
tuberculosis (N = 1) were the pathogens identified in the HIV 
DNA PCR-negative children who were ventilated. PCP (44%), 
mixed infections (36%) and nosocomial pneumonias (16%) 
were responsible for the majority of deaths in this cohort. The 
aetiology of the pneumonia for children managed at 
Ngwelezana was not determined. 
Discussion 
Rational allocation of limited intensive care facilities can only 
be accomplished with adequate knowledge of outcome of 
conditions requiring such care. Ethical concerns do not allow 
medical emergencies to be evaluated using double-blind 
randomised control studies, but where such cases are 
continually being denied optimal care due to the lack of 
facilities, investigational studies are deemed clinically justified. 
The most important finding of this study, the first in the world, 
is the lack of benefit of mechanical ventilation in HIV-infected 
children under 15 months of age with ALRI and ARF 
compared with similar children who were refused ventilatory 
support. This was especially so in infants under 3 months of 
age and those with WHO-defined very severe pneumonia. 
ORIGINAL ARTICLES 
HIV-exposed but uninfected children with similar severity of 
illness have better outcomes than HIV-infected children. 
Should HIV antibody-positive children be offered intensive 
care? In the USA, children with HIV-related acute respiratory 
failure requiring IPPV have ICU survival rates of 50- 81 %Y 
PCP was the commonest cause of ICU admission and had the 
worst outcomes.' The introduction of corticosteroids to the 
management of these children improved the short-term 
outcome, but long-term survival at 30 months remains the 
same at 0 - 60%.'-'" 
Poor prognostic factors have been identified in these studies. 
CD4 counts< 50 cells/pJ, lactate dehydrogenase (LDH) levels 
> 1 000 IU, serum albumin < 20 g/ dl, serum creatinine 
> 24 pg/ dl, a diagnosis of AIDS of less than 1 year's duration, 
persistent hypoxaemia and pneumothoraces have been 
associated with worse outcome/ but have not been tested in 
developing countries. 
A second important finding of this study was the high 
predictive value of the HIV antibody test for this population. 
The overall figure of 86.2% PCR positivity should be viewed in 
the context of the disease studied and the high HIV prevalence 
for the region. An estimated 12% of the general population 
served by these hospitals are HIV-infected.' It is useful for 
doctors working in these and similar regions to assume that a 
positive HIV antibody result in babies under 15 months 
requiring ventilation for pneumonia is suggestive of true HIV 
infection. Only splenomegaly and serum globulin > 35 g/1 
were useful in predicting HIV infection, although these 
features need verification. 
The use of the PCR to detect HIV-proviral DNA and the 
reverse transcriptase PCR to detect free virus have been widely 
used to identify HIV-infected infants reliably at all ages after 
birth. The commercial assays, while sensitive and specific, are 
costly and not readily available. The HIV DNA PCR assay 
utilised in this study has undergone prior evaluation and 
achieved sensitivities and specificities equal to the commercial 
kits, but is more affordable (D F York- personal 
communication). 
There are several limitations to the utilisation of these 
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findings. Although great effort was taken to ensure that the 
two groups would be comparable, the difference in the nurse/ 
patient ratios between the two groups, the lack of 
microbiological evaluations in the Ngwelezana cohort, the 
delay in transportation of cases to the PICU after acceptance, 
and the different locations where patients were nursed may 
have influenced the outcome significantly. No case received 
antiretroviral therapy and therefore these findings would only 
be applicable in HIV treatment-naive populations. 
In this limited study, conventional mechanical ventilation 
does not offer substantial gains over non-ventilatory care for 
HIV-infected children under 15 months of age with ALRI and 
ARF. HIV-exposed but uninfected children with similar illness 
fare better than HIV-infected children. Children with very 
severe pneumonia or those less than 3 months of age have the 
worst outcome. A positive HIV antibody test in children with 
ALRI and ARF has an 86.2% predictive value of true HIV 
infection. Only splenomegaly and a serum globulin of greater 
than 35 g/1 are predictive of true HIV infection. 
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